RE:RE:RE:RE:RE:bullish index
I agree, updating with details to better define what the company is accomplishing. I've wondered why they haven't... is it to keep their progress under wraps since the diabetic telemedicine screening segment is fairly new and Diagnos doesn't want to encourage competition by disclosing more than it has to? Maybe, as important as investor relations is, they concluded that putting much money into it before having something worth promoting is futile. So they held off until they created a bigger footprint. I'm thinking we're pretty damn close to having something big worth touting.
From what I understand about CARDS... while there are interested parties, the state of the market is holding back potential bidders. However, cuts have been made to that division which should be reflected in financials soon, I think.